Results 131 to 140 of about 4,765 (219)

Ibrutinib or non-BTK inhibitor therapy in relapsed Waldenström macroglobulinemia: a real-life multicenter Italian study. [PDF]

open access: yesBlood Adv
Autore F   +26 more
europepmc   +1 more source

Extent of bone marrow infiltration predicts disease progression in asymptomatic Waldenström macroglobulinemia. [PDF]

open access: yesDiscov Oncol
Danesin N   +14 more
europepmc   +1 more source

An Extremely Rare Cause of Protein-Losing Enteropathy: Waldenström Macroglobulinemia. [PDF]

open access: yesACG Case Rep J
Saab O   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy